MetaCap

MoonLake Immunotherapeutics (MLTX) News

NASDAQ: MLTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.07+0.04 (+0.36%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MLTX news summary

We found 4 recent headlines mentioning MoonLake Immunotherapeutics (MLTX): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, MLTX is up 0.36% at $11.07. The most recent story, "MoonLake Immunotherapeutics Consensus Price Target Raised 10.66% to $35.55", was published by Nasdaq on Nov 9, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest MoonLake Immunotherapeutics headlines

Stocks mentioned alongside MLTX

Compare MLTX